Apoptotic effects of the 'designer drug' methylenedioxypyrovalerone (MDPV) on the neonatal mouse brain

NeuroToxicology

Volumn 44, Issue , 2014, Pages 231-236

  Ádám, Ágota ^a   Gerecsei, László István ^a   Lepesi, Nikolett ^a   Csillag, András ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Apoptosis; Caspase 3; Cathinone; Designer drug; Nucleus accumbens

Indexed keywords

CASPASE 3; CASPASE 3 ANTIBODY; DESIGNER DRUG; ENZYME ANTIBODY; METHYLENEDIOXYPYROVALERONE; SODIUM CHLORIDE; UNCLASSIFIED DRUG; 1,3 BENZODIOXOLE DERIVATIVE; 3,4-METHYLENEDIOXYPYROVALERONE; PYRROLIDINE DERIVATIVE;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN CELL; BRAIN DEVELOPMENT; C57BL 6 MOUSE; CELL COUNT; CELL DENSITY; CELL TRANSFORMATION; CHEMOSENSITIVITY; CONTROLLED STUDY; CYTOTOXICITY; DEVELOPMENTAL STAGE; DRUG ABUSE; FETUS DEVELOPMENT; HIPPOCAMPAL CA1 REGION; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LOCOMOTION; MOUSE; NERVE CELL LESION; NEWBORN; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PYRIFORM CORTEX; RETROSPLENIAL CORTEX; THIRD TRIMESTER PREGNANCY; BODY TEMPERATURE; BRAIN TOXICITY; CELL STRUCTURE; CELLULAR DISTRIBUTION; CINGULATE GYRUS; DEGENERATIVE DISEASE; DENDRITE; DENTATE GYRUS; DRUG EFFECT; NERVE CELL; PRIMARY MOTOR CORTEX; ANIMAL; BRAIN; C57BL MOUSE; DRUG EFFECTS; FEMALE; MALE; METABOLISM; MOTOR ACTIVITY;

ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; BENZODIOXOLES; BODY TEMPERATURE; BRAIN; CASPASE 3; CELL COUNT; DESIGNER DRUGS; FEMALE; MALE; MICE; MICE, INBRED C57BL; MOTOR ACTIVITY; PYRROLIDINES;

EID: 84905243621     PISSN: 0161813X     EISSN: 18729711     Source Type: Journal    
DOI: 10.1016/j.neuro.2014.07.004     Document Type: Article

References (25)

1. Baumann M.H., Partilla J.S., Lehner K.R. Psychoactive bath salts: not so soothing. Eur J Pharmacol 2013, 698:1-5.
2. Baumann M.H., Partilla J.S., Lehner K.R., Thorndike E.B., Hoffman A.F., Holy M., Rothman R.B., Goldberg S.R., Lupica C.R., Sitte H.H., Brandt S.D., Tella S.R., Cozzi N.V., Schindler C.W. Powerful cocaine-like actions of 3,4-methylenedioxypyrovalerone (MDPV), a principal constituent of psychoactive 'bath salts' products. Neuropsychopharmacology 2013, 38:552-562.
3. Bayer S.A., Altman J., Russo R.J., Zhang X. Timetables of neurogenesis in the human brain based on experimentally determined patterns in the rat. Neurotoxicology 1993, 14:83-144.
4. Bento A.R., Baptista S., Malva J.O., Silva A.P., Agasse F. Methamphetamine exerts toxic effects on subventricular zone stem/progenitor cells and inhibits neuronal differentiation. Rejuvenation Res 2011, 14:205-214.
5. Cameron K.N., Kolanos R., Solis E., Glennon R.A., De Felice L.J. Bath salts components mephedrone and methylenedioxypyrovalerone (MDPV) act synergistically at the human dopamine transporter. Br J Pharmacol 2013, 168:1750-1757.
6. Carroll F.I., Lewin A.H., Mascarella S.W., Seltzman H.H., Reddy P.A. Designer drugs: a medicinal chemistry perspective. Ann NY Acad Sci 2012, 1248:18-38.
7. Dzietko M., Sifringer M., Klaus J., Endesfelder S., Brait D., Hansen H.H., Bendix I., Felderhoff-Mueser U. Neurotoxic effects of MDMA (ecstasy) on the developing rodent brain. Dev Neurosci 2010, 32:197-207.
8. Fantegrossi W.E., Gannon B.M., Zimmerman S.M., Rice K.C. In vivo effects of abused 'bath salt' constituent 3,4-methylenedioxypyrovalerone (MDPV) in mice: drug discrimination, thermoregulation, and locomotor activity. Neuropsychopharmacology 2013, 38:563-573.
9. Glennon R.A. Bath salts, mephedrone, and methylenedioxypyrovalerone as emerging illicit drugs that will need targeted therapeutic intervention. Adv Pharmacol 2014, 69:581-620.
10. Ikonomidou C., Bittigau P., Ishimaru M.J., Wozniak D.F., Koch C., Genz K., Price M.T., Stefovska V., Horster F., Tenkova T., Dikranian K., Olney J.W. Ethanol-induced apoptotic neurodegeneration and fetal alcohol syndrome. Science 2000, 287:1056-1060.
11. Jiménez A., Jordà E.G., Verdaguer E., Pubill D., Sureda F.X., Canudas A.M., Escubedo E., Camarasa J., Camins A., Pallàs M. Neurotoxicity of amphetamine derivatives is mediated by caspase pathway activation in rat cerebellar granule cells. Toxicol Appl Pharmacol 2004, 196:223-234.
12. Karila L., Reynaud M. GHB and synthetic cathinones: clinical effects and potential consequences. Drug Test Anal 2011, 3:552-559.
13. Magdum S.S. An overview of khat. Addict Disord Treat 2011, 10:72-83.
14. Marusich J.A., Grant K.R., Blough B.E., Wiley J.L. Effects of synthetic cathinones contained in bath salts on motor behavior and a functional observational battery in mice. Neurotoxicology 2012, 33:1305-1313.
15. Paxinos G., Franklin K.B.J. The mouse brain in stereotaxic coordinates 2008, Elsevier Academic Press, Amsterdam.
16. Poeggeler B., Rassoulpour A., Wu H.Q., Guidetti P., Roberts R.C., Schwarcz R. Dopamine receptor activation reveals a novel, kynurenate-sensitive component of striatal N-methyl-d-aspartate neurotoxicity. Neuroscience 2007, 148:188-197.
17. Saito M., Chakraborty G., Hegde M., Ohsie J., Paik S.M., Vadasz C., Saito M. Involvement of ceramide in ethanol-induced apoptotic neurodegeneration in the neonatal mouse brain. J Neurochem 2010, 115:168-177.
18. Simmler L.D., Buser T.A., Donzelli M., Schramm Y., Dieu L.H., Huwyler J., Chaboz S., Hoener M.C., Liechti M.E. Pharmacological characterization of designer cathinones in vitro. Br J Pharmacol 2013, 168:458-470.
19. Spiller H.A., Ryan M.L., Weston R.G., Jansen J. Clinical experience with and analytical confirmation of bath salts and legal highs (synthetic cathinones) in the United States. Clin Toxicol (Phila) 2011, 49:499-505.
20. Susick L.L., Lowing J.L., Provenzano A.M., Hildebrandt C.C., Conti A.C. Postnatal ethanol exposure simplifies the dendritic morphology of medium spiny neurons independently of adenylyl cyclase 1 and 8 activity in mice. Alcohol Clin Exp Res 2014, 10.1111/acer.12383.
21. Tomiyama K., Funada M. Cytotoxicity of synthetic cannabinoids on primary neuronal cells of the forebrain: the involvement of cannabinoid CB1 receptors and apoptotic cell death. Toxicol Appl Pharmacol 2014, 274:17-23.
22. Tulloch I.K., Afanador L., Zhu J., Angulo J.A. Methamphetamine induces striatal cell death followed by the generation of new cells and a second round of cell death in mice. Curr Neuropharmacol 2011, 9:79-83.
23. Vislobokov A.I., Mantsev V.V., Kuzmin A.V. Cocaine, amphetamine and cathinone, but not nomifensine and pargyline increase calcium inward current in internally perfused neurons. Life Sci 1993, 52:PL261-PL265.
24. Watterson L.R., Kufahl P.R., Nemirovsky N.E., Sewalia K., Grabenauer M., Thomas B.F., Marusich J.A., Wegner S., Olive M.F. Potent rewarding and reinforcing effects of the synthetic cathinone 3,4-methylenedioxypyrovalerone (MDPV). Addict Biol 2014, 19:165-174.
25. Zhu J.P.Q., Xu W., Angulo J.A. Methamphetamine-induced cell death: selective vulnerability in neuronal subpopulations of the striatum in mice. Neuroscience 2006, 140:607-622.